We are live on ! Find out more
KAPA

Kairos Pharma
KAPA

2 hedge funds and large institutions have $70K invested in Kairos Pharma in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.35% more ownership

Funds ownership: 0% → 0.35% (+0.35%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$66.8K
2
HF
HRT Financial
New York
+$25.8K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$51K +$66.8K +32,711 New
HF
2
HRT Financial
New York
$19K +$25.8K +12,609 New

KAPA Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Kairos Pharma (KAPA) for Q3 2024, worth a combined $70K.

Buyers outnumbered sellers: 2 funds opened new KAPA positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $66.8K.

  • 2 institutional investors held Kairos Pharma (KAPA) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $70K of Kairos Pharma stock for Q3 2024.
  • 2 funds opened new Kairos Pharma positions in Q3 2024 and 0 closed out, a net change of +2 holders.
  • The largest Kairos Pharma buyer in Q3 2024 was Virtu Financial, an estimated $66.8K added.

Based on aggregated 13F filings for Q3 2024.